WELL Health’s OceanMD and HEALWELL’s Intrahealth Announce Partnership to Expand Access to eReferral Healthcare Solutions

WELL Health subsidiary, OceanMD, and HEALWELL subsidiary, Intrahealth, announce a partnership to integrate OceanMD’s leading eReferral system across Intrahealth’s global network to enhance digital interoperability, streamline healthcare processes, and improve patient access to care.  This collaboration enables HEALWELL’s Intrahealth to make OceanMD’s eReferral system, which currently supports 120,000 eReferrals and eConsults monthly, available to a…

HEALWELL AI Provides Corporate Update on Capital Allocation Program and Value Creation Strategy

HEALWELL’s current goal is to achieve run rate revenues approaching $100 million by the end of the year from today’s current run rate of over $65 million. This goal is underpinned by a robust M&A pipeline where there are several advanced subjects including one signed LOI and helps the Company position itself to achieve profitability…

HEALWELL Provides Corporate Update Reflecting Strengthened Balance Sheet with $15.5 Million Reduction of Total Liabilities

HEALWELL is pleased to provide an update on its improved balance sheet with the reduction of approximately $15.5 million of liabilities in Q2-2024.    HEALWELL has successfully settled certain payment obligations related to the legacy MCI Medical Clinics Inc. (“MCI Ontario”) business, resulting in extinguishing $3.9 million in future liabilities including rent and operating costs,…

HEALWELL AI Announces Successful Closing of Two Strategic Acquisitions: VeroSource Solutions and BioPharma Services

HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma Services Inc., which boosts HEALWELL’s proforma annualized revenue run-rate to be greater than $65 million and significantly improves HEALWELL’s profitability. Serving five different provincial health clients across Canada, VeroSource is an end-to-end, customizable, cloud-based data interoperability platform that enables patients, care…

HEALWELL AI to Acquire BioPharma, one of Canada’s largest CROs, to Expand and AI-Enable Clinical Research Offerings

HEALWELL has entered into an agreement to acquire BioPharma Services Inc., one of the largest full-service Contract Research Organizations (“CRO”) headquartered in Canada. Biopharma is focused on bioequivalence and early-stage clinical trials, with over 2,200 clinical trials completed to date with approximately 250 pharma clients since inception. BioPharma is expected to generate between $35 to…

HEALWELL AI Participates in Leading-Edge Research on Chronic Kidney Disease Highlighting the Potential of its AI Powered Clinical Co-Pilot

HEAWELL AI’s Clinical Co-Pilot technology participated in recently published evidence showing the integration of a highly accurate machine model for Chronic Kidney Disease (“CKD”) progression when paired with Electronic Health Record (“EHR”) linked clinical decision support, improves guideline-recommended testing in patients with CKD. HEALWELL’s subsidiary Khure Health (“Khure”) co-authored an abstract that was published this month in…